FGF-19 recombinant protein product blog
Tags: Recombinant Protein; Fibroblast Growth Factor-19; FGF-19; FGF-19 recombinant protein;
The FGF-19 fgf19 (Catalog #MBS555533) is a Recombinant Protein and is intended for research purposes only. The product is available for immediate purchase. The Recombinant Human Fibroblast Growth Factor-19 reacts with Human and may cross-react with other species as described in the data sheet.The FGF-19 fgf19 product has the following accession number(s) (GI #4826726) (NCBI Accession #NP_005108.1). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Please refer to the product datasheet for known applications of a given recombinant protein. We\'ve tested the Recombinant Human Fibroblast Growth Factor-19 with the following immunoassay(s):
Testing Data (Image: FGF-19 protein structure and sequence)
Our knowledge of the role of proteins in cellular processes is continually evolving. Most proteins, including Fibroblast Growth Factor-19 are typically involved in one or more signaling pathways or biological processes. Professionally manufactured recombinant proteins are increasingly becoming essential and commonplace tools for elucidating new knowledge about the role of proteins in both health and disease.
The following patways have been known to be associated with this gene. Brain, Embryonic Tissue, Intestine, Parathyroid, Uterus tissues are correlated with this protein. FGF-19 also interacts with the following gene(s): CYP7A1, FGF18, FGF20, FGF23, FGF4, FGF8, FGF9, FGFR1, FGFR4, KLB. Atherosclerosis, Carcinoma, Hepatocellular, Cholestasis, Diarrhea, Fatty Liver, Inflammation, Insulin Resistance, Kidney Diseases, Liver Diseases, Weight Loss are some of the diseases may be linked to Recombinant Human Fibroblast Growth Factor-19.